Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspar in chronic high-level spinal cord injury
NCT05041322Phase 2Completed
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Nov 2020
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in spinal cord injury (SCI), sponsored by Spaulding Rehabilitation Hospital. Started Nov 2020; status: completed.
02
Drugs
buspirone
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT05041322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05041322.